Healthcare in Nigeria: funding deals and active investors
One of the best-documented segments on the platform. Latest rounds, investors who lead them, tickets and instruments — Healthcare, Nigeria.
5
deals recorded
2
over 12 months
142 k$
median disclosed ticket
5
identified investors
Key findings
- 5 funding deals recorded (Healthcare, Nigeria) since 2014, involving 5 companies and 5 identified investors. 2 of them over the last 12 months.
- Median disclosed ticket: 142 k$; half of the deals fall between 142 k$ and 142 k$ (1 amounts disclosed out of 5, 142 k$ in total).
- Where the money goes: Clinics and hospitals (40 %), Labs and imaging (20 %), Pharmaceutical manufacturing (20 %).
- Most frequent stage: Growth (80 %); most used instrument: Senior debt (40 %).
- Most active investors: AFIG Funds (1), CardinalStone (1), Cascador (1).
- 0 % of deals are syndicated (at least two investors around the table).
Industries
- Clinics and hospitals2
- Labs and imaging1
- Pharmaceutical manufacturing1
- Pharmacy and drug distribution1
Stages
- Growth4
Instruments
- Senior debt2
- Equity2
Deals per year
| Year | Deals | Disclosed amounts |
|---|---|---|
| 2022 | 1 | — |
| 2026 | 2 | 142 k$ |
Most active investors
- AFIG Funds1 deal
- CardinalStone1 deal
- Cascador1 deal
- IFC (International Finance Corporation)1 deal
- Verod Capital1 deal
Latest deals
| Company | Date | Disclosed amounts | Lead |
|---|---|---|---|
| Afya CareClinics and hospitals · Nigeria | Jan 1970 | undisclosed | CardinalStonesource |
| ForticsClinics and hospitals · Nigeria · Growth | Jun 2026 | 142 k$ | Cascadorsource |
| NSIA Advanced Medical Services Limited (MedServe)Labs and imaging · Nigeria · Growth | Feb 2026 | undisclosed | IFC (International Finance Corporation)source |
| MedplusPharmacy and drug distribution · Nigeria · Growth | Mar 2022 | undisclosed | Verod Capitalsource |
| Nigerian-German ChemicalsPharmaceutical manufacturing · Nigeria · Growth | Aug 2014 | undisclosed | AFIG Fundssource |
See also
Method: published funding deals (press releases, specialised media), recorded by Invest Matching's news monitoring and reviewed before integration. Amounts in US dollars; deals without a disclosed amount count in the totals, not in the medians.